StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) KPIs and segments

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.91−0.11 (-3.64%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Galectin Therapeutics's business

Coming soon

This tab will track the numbers specific to Galectin Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?